Get the app!
Back to Trades
Total Value
$85.0K
Net $59.7K sold
Filing Date
Jul 24, 2026
1 transaction
Sales
$59.7K
1 transaction

Trade Summary

On Jul 24, 2026, Pande Atul, Director, sold $85.0K of Immunovant, Inc. (IMVT) across 1 transaction. The filing covers Common Stock and reflects net selling of $59.7K. Reported prices ranged from $8.43 to $39.80. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
Immunovant, Inc.
Ticker Symbol
IMVT
CIK
0001764013

Insider Information

Role
Director
Location
DURHAM, NC

Filing Details

Filing Date
Jul 24, 2026
Transaction Date
Jul 24, 2026
Accession Number
0001643071-26-000007
Form Type
4
Net Trading Amount
-$59.7K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jul 24, 2026Common Stock1,500$8.43Exercise$12.6K
Jul 24, 2026Common Stock1,500$39.80Sale$59.7K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Jul 24, 2026IMVT derivative1,500$8.43Exercise$12.6K

Want live alerts when Pande Atul trades again?

Download Insider Trades to track IMVT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.
  2. (F2)Reflects an award of stock options to purchase Common Shares that is fully vested.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.